1 |
Ascorbic acid
| [1] Ascorbic acid Ascorbic acid | [4] Acidum ascorbicum Acidum ascorbicum; Ascorbic acid; Iron; Vitamin C; | - | - | [8] 10 10, 97, 192, 206, 210, 211, 212, 298 |
2 |
Nitrogen
| [1] Nitrogen Nitrogen | [1] Nitrogen Nitrogen; | - | - | [6] 5 5, 6, 17, 171, 211, 299 |
3 |
Methylprednisolone
| [1] Methylprednisolone Methylprednisolone | [4] Medrol Medrol; Methylprednisolon; Methylprednisolone; Methylprednisolone acetate; | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
4 |
Oxandrolone
| [1] Oxandrolone Oxandrolone | [1] Oxandrolone Oxandrolone; | [1] AR AR 💬 | [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | [2] 211 211, 285 |
5 |
Methylprednisolone sodium succinate
| [1] Methylprednisolone Methylprednisolone | [4] Medrol Medrol; Methylprednisolon; METHYLPREDNISOLONE; METHYLPREDNISOLONE ACETATE; | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
6 |
Methylprednisolone acetate
| [1] Methylprednisolone Methylprednisolone | [4] Medrol Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE; | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
7 |
Bosentan
| [1] Bosentan Bosentan | [2] Bosentan Bosentan; Tracleer; | [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [11] 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
8 |
Sildenafil citrate
| [1] Sildenafil Sildenafil | [6] Mysildecard Mysildecard; REVATIO; SILDENAFIL; SILDENAFIL CITRATE; SILDENAFILO; VIAGRA; | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [17] 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 |
9 |
Methylprednisolone hemisuccinate
| [2] Methylprednisolone Methylprednisolone, Methylprednisolone hemisuccinate | [8] Medrol Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE; Methylprednisolone hemisuccinate; Methylprednisolone sodium succinate; Methylprednisolone succinate; Solu-Medrol; | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [55] 2 2, 6, 11, 13, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 49, 50, 50, 51, 51, 53, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 97, 127, 145, 162, 164, 211, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
10 |
Methylprednisolone sodium phosphate
| [1] Methylprednisolone Methylprednisolone | [4] Medrol Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE; | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
11 |
Methylprednisolone suleptanate
| [1] Methylprednisolone Methylprednisolone | [4] Medrol Medrol; Methylprednisolon; METHYLPREDNISOLONE; Methylprednisolone acetate; | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
12 |
Ambrisentan
| [1] Ambrisentan Ambrisentan | [3] Ambrisentan Ambrisentan; Letairis; Volibris; | [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [7] 51 51, 84, 85, 86, 88, 210, 211 |
13 |
Bosentan
| [1] Bosentan Bosentan | [2] Bosentan Bosentan; Tracleer; | [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [11] 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
14 |
Poractant alfa
| [1] Poractant alfa Poractant alfa | [1] Curosurf Curosurf; | - | - | [1] 211 211 |
15 |
Sildenafil
| [1] Sildenafil Sildenafil | [6] Mysildecard Mysildecard; Revatio; Sildenafil; Sildenafil citrate; SILDENAFILO; Viagra; | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [17] 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 |